Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nicolò Santi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Università degli Studi di Modena e Reggio Emilia (UNIMORE), via Campi 103, 41125 Modena, Italy. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Click Chemistry, Boronic Acids, beta-Lactamases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Ministero dell'Istruzione e del Merito, NIH HHS.
Abstract (Originalsprache)
In this study, we evaluated in situ click chemistry as a platform for discovering boronic acid-based β-lactamase inhibitors (BLIs). Unlike conventional drug discovery approaches requiring multi-step synthesis, protection strategies, and extensive screening, the in situ method can allow for the generation and identification of potent β-lactamase inhibitors in a rapid, economic, and efficient way. Using KPC-2 (class A carbapenemase) and AmpC (class C cephalosporinase) as templates, we demonstrated their ability to catalyse azide-alkyne cycloaddition, facilitating the formation of triazole-based β-lactamase inhibitors. Initial screening of various β-lactamases and boronic warheads identified compound 3 (3-azidomethylphenyl boronic acid) as the most effective scaffold for kinetic target-guided synthesis (KTGS). KTGS experiments with AmpC and KPC-2 yielded triazole inhibitors with Ki values as low as 140 nM (compound 10a, AmpC) and 730 nM (compound 5, KPC-2). Competitive inhibition studies confirmed triazole formation within the active site, while an LC–MS analysis verified that the reversible covalent interaction of boronic acids did not affect detection of the in situ-synthesised product. While KTGS successfully identified potent inhibitors, limitations in amplification coefficients and spatial constraints highlight the need for optimised warhead designs. This study validates KTGS as a promising strategy for BLI discovery and provides insights for further refinement in fighting β-lactamase-mediated antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Università degli Studi di Modena e Reggio Emilia (UNIMORE), via Campi 103, 41125 Modena, Italy.
- Department of Biotechnological and Applied Clinical Sciences, Università degli Studi dell'Aquila, via Vetoio, 67100 L'Aquila, Italy.
- Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
- Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
- Clinician Scientist Investigator, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
- Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
ORCID-Profile: Nicolò Santi, Mariagrazia Perilli, Robert A Bonomo, Francesco Fini, Fabio Prati, Emilia Caselli
Förderung
- European Union
- Ministero dell'Istruzione e del Merito
- NIH HHS
- Cleveland Department of Veteran Affair
- European Union’s Horizon Europe research and innovation programme under the Marie Sklodowska-Curie grant agreement
- Ministry of University and Research of Italy (MIUR)—PRIN-2022
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)
- Cleveland Department of Veterans Affairs
Zitieren
APA
Santi, N., Piccirilli, A., Corsini, F., Taracila, M. A., Perilli, M., Bonomo, R. A., Fini, F., Prati, F., & Caselli, E. (2025). Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094182
Vancouver
Santi N, Piccirilli A, Corsini F, Taracila MA, Perilli M, Bonomo RA, et al. Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094182
BibTeX
@article{Santi2025,
author = {Santi, Nicolò and Piccirilli, Alessandra and Corsini, Federico and Taracila, Magdalena A and Perilli, Mariagrazia and Bonomo, Robert A and Fini, Francesco and Prati, Fabio and Caselli, Emilia},
title = {Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094182}
}
EUVIMED